Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study

Published:2024-08 Issue: Volume:36 Page:100814
ISSN:2667-193X
Container-title:The Lancet Regional Health - Americas
language:en
Short-container-title:The Lancet Regional Health - Americas

Author:

Narasaki Yoko,Kovesdy Csaba P.,You Amy S.,Sumida Keiichi,Mallisetty Yamini,Surbhi Satya,Thomas Fridtjof,Amin Alpesh N.,Streja Elani,Kalantar-Zadeh Kamyar,Rhee Connie M.^ORCID

Publisher

Elsevier BV

Reference43 articles.

1. Association of glycemic status during progression of chronic kidney disease with early dialysis mortality in patients with diabetes;Rhee;Diabetes Care,2017

2. Glycemic status and mortality in chronic kidney disease according to transition versus nontransition to dialysis;Rhee;J Ren Nutr,2019

3. Therapeutic considerations for antihyperglycemic agents in diabetic kidney disease;Neumiller;J Am Soc Nephrol,2017

4. Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease;Rhee;Curr Opin Nephrol Hypertens,2022

5. Glucose homeostasis, hypoglycemia, and the burnt-out diabetes phenomenon in kidney disease;Rhee;Semin Nephrol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of infection lower with SGLT2i than DPP4i;Reactions Weekly;2024-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP